Dr Robert Glynne-Jones is Consultant Clinical Oncologist at Mount Vernon Hospital, Watford and Barnet General Hospitals in London, where he is the Macmillan Lead Clinician in Gastrointestinal and Colorectal Cancer.
Dr Glynne-Jones is also Chief Medical Advisor to the national UK charity Bowel Cancer UK, and has a major interest in communications skills and patient choice.
He is a member of the European Society for Therapeutic Radiology and Oncology, the EORTC, ESMO and the American Society of Clinical Oncology. He plays an active role in the UK NCRI colorectal research group.
In the past he has been a member of NICE committees responsible for guidance for colorectal cancer and for producing quality standards for colorectal cancer, and is currently a member of a NICE committee examining Lynch syndrome and mismatch repair testing.
His major research interest is in rectal and anal cancer and in phase I, and translational research in chemoradiation.
He has more than 150 peer reviewed publications.
Current areas of research include the integration of immune checkpoint inhibitors into chemoradiation schedules in anal cancer and rectal cancer, the investigation of predictive factors for response and resistance to chemoradiation in anal and rectal cancer, DCE-MRI changes, and the optimal timing for surgery after chemoradiation.